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Background: Reconstruction of bone fractures and defects remains a big challenge in orthopedic surgery. 
While regenerative engineering has advanced the field greatly using a combination of biomaterial 
scaffolds and stem cells, one matter of difficulty is inducing osteogenesis in these cells. Recent works have 
shown electricity’s ability to promote osteogenesis in stem cell lines when seeded in bone scaffolds; 
however, typical electrical stimulators are either (a) externally housed and require overcomplex 
percutaneous wires be connected to the implanted scaffold or (b) implanted non-degradable devices 
which contain toxic batteries and require invasive removal surgeries. 
Objective: Here, we establish a biodegradable, piezoelectric Poly-L-Lactic Acid (PLLA) scaffold that uses 
external, non-invasive ultrasound to generate an electric charge that promotes stem cell osteogenesis. 
Methods: Demonstration of this system included (1) development of a piezoelectric PLLA mesh, (2) 
verification of its piezoelectric efficacy and degradation, (3) manufacturing of a PLLA scaffold, (4) in vitro 
testing of the system’s ability to enhance bone regeneration compared to a control, and (5) using 
assessments of cell proliferation and differentiation through protein, mineral, and gene assays. 
Results: Ultimately a 3000rpm electrospun PLLA nanofiber film that could output 40mV when stimulated 
with 40kHz 0.4W/cm2 ultrasound was assembled into a bone scaffold and seeded with adipose-derived 
stem cells (ADSCs). In vitro testing showed that relative to a control, in cells subjected to the experimental 
conditions alkaline phosphatase production increased 5-fold, mineral production increased 18-fold, 
osteocalcin gene 40-fold, and osterix gene 100-fold. 
Conclusion: The production of surface-level charge from ultrasonic stimulation of PLLA and the use of that 
charge to promote osteogenic differentiation in ADSCs was successfully demonstrated. The fact that PLLA 
was successfully used in combination with externally applied ultrasound to produce electrical charge 
opens up new frontiers for the field of tissue regeneration. This advancement helps make tissue 
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Introduction to Tissue Engineering 
Classical tissue regenerative engineering is an interdisciplinary field of advanced material science, 
cell biology, and developmental biology, with the aim of promoting the regeneration of complex tissues 
and organs [1]. In this process, natural or synthetic scaffolds, cells, and growth factors combine to form a 
construct, structurally, functionally, and mechanically similar to the native tissue that requires repair [2]. 
The field began around the 1970s when chondrocytes were for the first time seeded onto spicules of bone 
[3]. Although no new tissue was generated, it revealed the importance of the substrate cells were seeded 
on. Whereas naturally occurring scaffolds having physical and chemical properties similar to that of the 
native tissue, they could not be manipulated for experimentation or improvement thus resulting in 
unpredictable outcomes. When this idea developed in the 1980s into the concept of designing artificial 
scaffoldings for cell delivery as opposed to seeding cells onto available natural substrates, the true birth 
of tissue engineering occurred – one focused less on the cells themselves and more on how they can be 
physically and chemically directed towards growth [3]. 
Introduction to Bone Regeneration 
It is well known that bone disorders such as osteoporosis, osteoarthritis, and bone fractures, 
commonly occur due to abnormal physiology or physical injury. Reconstruction of bone fractures and 
defects has for a long time been an area of focus in orthopedic surgery [4]. The most common treatment 
options, replacement allografts and autografts, face many issues. Allografts, bone grafts from a donor, 
usually suffer from problems of limited supply, donor site infection, and host immune rejection [5]. 
Autografts, grafts sourced from other parts of that individual’s body invite additional complications at the 
donor site [5]. The second most common treatment option, long bone fixation, is highly invasive, risky, 
and painful [4]. Regenerative and tissue engineering strategies, which employ a synergistic combination 
of biomaterial scaffolds, stem cells, and/or small-molecule therapies, have therefore emerged as an 
important area of study [2]. 
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Bone regenerative engineering specifically aims to create stable, bioactive, and native tissue-like 
scaffolds that can repair bone damages [6]. These scaffolds are often combined with osteogenic or stem 
cells to create replacement tissue grafts with enhanced regenerative capability. Several techniques and 
strategies have emerged to promote bone regeneration. However, many of these novel treatments still 
suffer from issues of their own. One great challenge and key matter of difficulty is inducing osteogenesis, 
bone formation, in adipose-derived stem cells (ADSCs) and bone marrow-derived stem cells (BMDSCs) and 
reconstructing tissues with sufficient mechanical strength and native tissue-like function [7]. 
When this differentiation occurs erroneously, fibrous connective tissue rapidly occupies the bony 
defect rather than normal bone formation occurring [8]. The resulting fibrous connective tissue buildup, 
with its low mechanical strength and cartilage-like structure, creates defective bone [8]. To address these 
issues, people have researched biochemical stimuli including enhanced blood plasma, novel biomaterial 
scaffolds, and various growth factors that can push stem cells away from the fibrous connective tissue 
direction of differentiation and towards the bone side of regeneration; however, most attention was put 
into the chemical and biological behaviors [9]–[12]. Physical stimulation of bone has been not extensively 
researched or utilized clinically in bone regeneration efforts and warrants a greater understanding. 
Introduction to Use of Physical Stimulation in Bone Regeneration 
Since bone is exposed to multiple internal and external physical forces, however, biomechanical 
environment plays an important role in maintaining, repairing, and remodeling its tissues to meet 
functional demands and maintain the tissue homeostasis [13]. In fact, the physical properties of the cell 
microenvironment are equally important as the biochemical properties. For example, it has been shown 
that altering the stiffness of the extracellular matrix (ECM) could direct stem cell differentiation, with 
increasing stiffness directing differentiation toward more mechanically competent tissues, such as 
cartilage and bone, and away from the more delicate adipose and neuronal tissues [12]. Physical stimuli, 
including mechanical forces, ultrasound, shock waves, laser, electromagnetism, and electrical have 
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already shown active roles in bone regeneration and fracture healing in vitro and in vivo [14]. Figure 1 
summarizes these common physical stimulations.  
All of these physical stimulations have significant impacts on cell fate and behavior through 
various intracellular signaling pathways. This suggests that the use of such stimuli can be a promising 
strategy to improve bone fracture healing and regeneration. To date, some physical manipulations have 
already been introduced into clinical applications for bone regeneration, however, others have faced 
some difficulties. Knowledge of these advancements in physical stimulation for bone regeneration is 
important for the development of future smart tissue grafts that can repair bone in novel ways. 
Figure 1. Schematic of Various Physical Stimulation Enhancements For Bone Regeneration: (1) Step one of all tissue engineering 
strategies is harvesting the appropriate stem cell line. (2) Step two is seeding the cells in an artificial scaffold. In this case, the 
scaffold used is a piezoelectric PLLA scaffold. (3) Step three in this method of bone regeneration is the application of physical 
stimulation. The four most common types are mechanical, ultrasound, shock wave, and electromagnetic stimulation. (4) The last 




Mechanical forces are one type of physical stimulation that has been adopted into clinical practice 
[15]. It is well known that both extrinsic and intrinsic mechanical forces can induce tissue resistance and 
adaptation. The induced tissue forces are transmitted to the micromechanical environment of resident 
cells and thus influence the intracellular forces. Cells can subsequently modify their micromechanical 
environments via cytoskeletal rearrangement or molecular cascade transduction activation. This 
ultimately alters the synthesis or degradation of the extracellular matrix and feeds back to alter cellular 
sensitivity to incoming mechanical forces [16]. Studies have demonstrated that appropriate mechanical 
forces are important for normal bone cell localization, orientation, metabolism, and homeostasis [17]. The 
two most common mechanical forces that contribute to this are cyclic strain and fluid shear stress [18]. 
Cyclic strain describes the cycles of loading and unloading that cause the compression and 
relaxation of the ECM, which induce strain on the bone cells. Cyclic strain includes repeated tensile strain 
(pulling apart) as well as compressive strain (pushing together) of the tissue. Bone is constantly exposed 
to cyclic strain when an individual body is moving in daily life. The magnitude of tensile strain is important 
in bone development and the fate determination of mesenchymal stem cells (MSCs) and has reportedly 
been related to inhibition of adipogenesis (a process balancing osteogenesis and chondrogenesis) [19]. In 
mouse adipose-derived mesenchymal stem cells (ADSCs), cyclic tensile strain has also been shown to 
significantly reduce adipogenesis [20]. Studies have shown cyclic strain could increase the bone-to-
adipose ratio by upregulating the expression of actin-associated proteins, and activation of stretch-
activated cation channels [21]. Elements of the cytoskeleton bridging actin fibers to the nuclear 
membrane also have been shown to play an important role in osteogenesis during this mechanical 
stimulation [22]. 
The other common mechanical force that has been studied to aid in bone development and stem 
cell osteogenesis particularly is fluid shear stress -- the pulsatile or oscillating shear stress on the 
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musculoskeletal system caused by the flow of blood in the circulatory system [23]. Studies have proved 
the application of both continuous flow and pulsating fluid flow increases osteogenic differentiation of 
ADSCs as compared to static cultures [24]. Studies of fluid shear stress have shown pulsating fluid flow to 
produce the greater osteogenic induction with gene expression of runt-related transcription factor 2 
(RUNX2), an indicator of early osteogenesis, increasing significantly and expression of osteopontin (OPN), 
an indicator of late osteogenesis, remaining unchanging after 3 hours of application [25]. These studies 
suggest pulsating fluid flow may affect the early stages, but not the late stages of osteogenic 
differentiation [25]. The enhancement of osteogenesis from fluid flow relates to the distribution of 
nutrient and growth factors in the cell with enhanced expression of bone-specific markers being found in 
a uniform distribution in perfusion cultures and only the outer regions in static cultures [24]. Thus, the 
improved osteogenesis from the fluid flow may be attributed to the better distribution of nutrients and 
growth factors. 
Ultrasound 
Besides mechanical stimulation, ultrasound (US) in the 3-10 MHz range is one of the well-
established therapeutic physical stimuli for bone healing [26]. Ultrasound refers to longitudinal wave 
propagation, a special type of sonic wave with a frequency greater than 20 kHz (the upper limit of human 
audibility), that causes localized oscillation of particles. Since ultrasound was first reported to stimulate 
bone healing in 1950, numerous efforts have been put over several decades to prove its therapeutic 
effects in humans [26]–[28]. In particular, low-intensity pulsed ultrasound stimulation (LIPUS), using 
intensities less than 50 mW/cm2, has been reported to improve ECM synthesis, accelerate bone healing, 
and reactivate failed healing processes [28], [29]. This use of ultrasound to improve bone regeneration 
has been approved by the United States Food and Drug Administration (FDA) for human applications since 
1994 [30]. In in vitro cell studies, LIPUS was found to enhance the expression of osteoblast maturation 
markers, such as osteocalcin (OCN) gene, bone sialoprotein (BSP), and calcium (Ca2+) [31]–[35]. 
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LIPUS-induced bone healing can occur by the processes of inflammation, soft callus formation, 
angiogenesis (development of new blood vessels), early osteogenesis, bone formation, and bone 
remodeling [36]. There are several theories to illustrate these mechanisms. In the first theory, the 
oscillatory displacement of the cell membrane caused by the ultrasound wave triggers oscillatory 
displacement between intracellular elements of different densities [37]. The very low strains induced by 
the ultrasound on cells in vitro induces fluidization of the cytoskeleton and acceleration of cytoskeletal 
remodeling [38]. Another theory is the bilayer sonophore model, in which the ultrasound application pulls 
the cell membrane lipid layers apart and pushes them back together cyclically, leading to 
intramembranous hydrophobic spaces expanding and contracting accordingly [39]. In the fourth theory, 
ultrasound induces intracellular stress and strain maximized within the cell at two distinct resonant 
frequencies. Stimulated load-inducible gene expression, therefore, is maximized when the excitation 
frequency matches the cell’s resonant frequency [40]. A final popular theory posits ultrasound can 
modulate the microenvironment by heating it, thus regulating thermo-sensitive enzymes like 
metalloproteinase, which are important for bone matrix remodeling [41]. 
Shock Waves 
Shock waves, a kind of short-duration, acoustic pressure wave with an intensity between 30 MPa 
and 100 MPa have also been shown to be an effective form of physical stimulation [42]. These waves can 
be produced by various generators including hydraulic, electromagnetic, and pneumatic [42]. After 
propagating into the tissue, shock waves result in cavitation, the formation of micro-bubbles in areas of 
low pressure on the focal area. Shock waves have been introduced to increase cell membrane 
permeability and facilitate the delivery of macromolecules into cells [43]. Clinical use of shock waves, 
referred to as extracorporeal shock wave therapy (ESWT), is noninvasive and focused solely on the 
treatment area. In bone, ESWT is known to relieve pain, reduce inflammation, induce neo-angiogenesis, 
and stimulate stem cell activities thus improving tissue regeneration and healing [44]–[46]. It has been 
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shown to restore the healing process in cases of non-unions (a serious complication of bone fractures) 
[47], loosen the bone cement during revision arthroplasty (a follow-up procedure to a total knee 
replacement) [48], and enhance bone callus formation during bone lengthening [49]. In studies regarding 
osteoarthritis (OA), compared to a control group, the ESWT-treated group showed an increased osteocyte 
count, higher percentage of subchondral trabecular bone, and greater expression of dentin matrix protein 
(DMP1), an osteocyte marker [50]. Increased proliferation and migratory capacity were also shown in 
human BMDSCs when exposed to shock waves [51]. ADSCs exposed to ESWT have also shown enhanced 
production of osteogenic markers such as RUNX2, alkaline phosphatase (ALP), and mineralized Ca2+ 
matrix. The mechanisms of shock waves’ effects on bone healing have been found to be related to the 
micro-fractures and cavitation they induce [52]. The micro-fractures and cavitation trigger the initiation 
of remodeling cycles and neovascularization [46], [53]. Thus, they regulate the growth and maturation of 
osteoprogenitor cells, membrane polarization, expression of bone morphogenetic proteins (BMPs), and 
activation of the mechano-transduction pathways that are related to acoustic stimulations [44], [54]–[56]. 
During the mechano-transduction process, mechanosensory components in cell membranes such as 
integrins, ion channels, and various sensory and growth factor receptors are activated by shock wave-
induced forces. 
Laser 
Low-level laser therapy (LLLT) with proper doses and output powers has also been reported to 
stimulate cellular metabolism, increase protein synthesis, and subsequently enhance bone regeneration 
[57]. LLLT has been proven to elevate the structural stiffness of bone callus and increase mitochondrial 
respiration and adenosine triphosphate (ATP) synthesis [58]. However, some researchers have also found 
LLLT to accelerate bone formation through increased osteoblastic activity, vascularization, and better 
organization of collagen fibers [59]. 
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Introduction to Use of Electrical Physical Stimulation 
One of the most researched methods of physical stimulation proven effective for bone 
regeneration is electrical stimulation (ES). Electrical stimulation treatment is especially fitting given bone 
tissue’s unique relationship with electricity. Bone tissue, specifically the collagen-hydroxyapatite matrix 
comprising it, has a unique property called piezoelectricity, which allows the tissue to generate electricity 
in response to mechanical stress and vice versa [60]. The polar, uniaxial orientation of collagen enables it 
to displace its charge carriers from the inside of the molecule to the outside when stressed in an 
appropriate way [61]. The exact amplitude of the electrical potential generated, however, is determined 
by the rate, magnitude, and orientation of the applied load and the resulting bone deformation. Normally, 
when bone is bent, the concave sides (under compressive stress) become negatively charged and the 
convex sides (under tensile stress) become positively charged, which makes the bone grow more on the 
compressive side and degrade more on the stretched side [62]. Through this same mechanism, stimulation 
of bone regeneration is also possible through electrical-induced pathways. 
The exact mechanism underlying the intracellular signal transduction of ES in bone repair is still 
unclear. Several hypotheses have been reported. (1) ES could alter the ion flux via cell membrane proteins 
(such as ion channels, transporters, pumps, and enzymes) and subsequently lead to an ion concentration 
change, which may cause depolarization of excitable cells and trigger downstream cellular signaling [63]. 
(2) Applied current could change the cell gap junctions, which affect the exchange of certain signaling 
molecules such as calcium, cyclic nucleotides, and inositol phosphates [64]. Much evidence indicates that 
gap junction communication is necessary for the development and maintenance of a differentiated 
osteoblast phenotype, including the production of ALP, OCN, bone sialoprotein, and collagen type I (COL 
I) [65]. (3) ES may also affect ligand-receptor binding by changing the conformation or expression of 
receptors [66]. (4) ES may also stimulate higher metabolic activity, which could induce intracellular ATP 
depletion and thus alter the membrane characteristics such as endo- and exocytosis, adhesion, and 
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motility [67]. (5) ES could change ECM compositions by affecting the ECM components including soluble 
ions and charged groups in glycosaminoglycans (GAGs) and proteins [68]. 
There are three main administrations of electric stimulation. These are summarized in Figure 2 [69]. 
Two methods produce electrical fields and one method applies a direct electric charge. (a) 
Capacitive coupling (CC): Two capacitive coupled electrodes are situated on the skin on both sides of the 
treatment site. An external power source is then attached to the electrodes, which induces an electric 
field (EF) at the treatment site. (b) Inductive coupling (IC): An electromagnetic current-carrying coil 
attached to an external power source is placed on the skin overlying the treatment site. The coil generates 
pulsed electromagnetic fields (PEMFs), which induce an electrical field at the site. (c) Direct current (DC): 
A cathode is implanted at the treatment site which is attached to either a subcutaneous power source or 
an external power source to generate an electric charge at the fracture site. [69] 
Capacitive Coupling 
Capacitive coupling stimulation involves two capacitive coupled electrodes utilizing external 
power to induce a physiological electric field around a treatment site. Physiological electric fields serve as 
Figure 2. Main Methods of Administering Electric Stimulation to Bone: (a) Capacitive coupling (CC): coupled electrodes situated 
externally creating an electric field. (b) Inductive coupling (IC): an electromagnetic current-carrying coil situation on the skin 
generates pulsed electromagnetic fields (PEMFs), which induce an electrical field. (c) Direct current (DC): a cathode is implanted at 
the treatment site which is attached to either a subcutaneous or an external power source to generate an electric surface charge.  
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an effective tool to control and adjust cellular and tissue homeostasis. The human body generates a 
biological EF ranging between 10 mV and 60 mV at various locations [70]. Bioelectricity is very important 
in the wound healing process. When a wound is created, a steady EF is initiated. This endogenous EF 
guides cell migration toward the wound edge. In 1953, researchers confirmed this an in in vivo rabbit 
model when they applied a continuous electrical current to a rabbit femur for 3 weeks and demonstrated 
new bone formation around the cathode [71]. Since then, the use of EFs for bone healing applications has 
been widely researched [72]. 
Inductive Coupling 
Inductive coupling, utilizing pulsed electromagnetic fields to induce an electrical field at a 
treatment site, has added benefits beyond those typically seen with CC [73]. Under IC stimulation, 
osteoblasts have been found to exhibit increased osteogenesis caused by elevated expression of 
transforming growth factor-beta 1 (TGF-β1) [74] and BMP2/4 [75] and reinforced intracellular Ca2+ 
transients [76]. In a rat model, long-term IC stimulation treatment alleviated lumbar vertebral 
osteoporosis by increasing bone formation and suppressing bone resorption [77]. Researchers have 
identified a specific extremely low-frequency pulsed electromagnetic field (ELF-PEMF) in the 10-90.6 Hz 
frequency that supports human osteoblast function [78], [79]. The ELF-PEMF increases production of non-
toxic amounts of reactive oxygen species induced anti-oxidative defense mechanisms in these cells [78], 
[79]. In bone tissue, ELF-PEMF treatment was found to modulate the cell cycle of MSCs of different origins 
to enhance their differentiation and proliferation [80]. This could be seen by their enhanced production 
of ECM and growth and differentiation factors including TGF-β1 and BMPs [80]. Besides frequencies that 
support osteoblast function, a wide range of electromagnetic stimulation frequencies between 2 Hz and 
123 Hz have been shown to be effective in improving osteogenic differentiation in ADSCs [81]. The 
stimulation has been found to increase intracellular Ca2+, ALP activity, and cytoskeleton tension after 14 




Direct current has also been observed to enhance osteogenesis when cells are stimulated with a 
current of 5–100 μA [83]. Electrical potentials have been proven to play an important role in bone cell 
proliferation, migration, and remodeling both in vitro and in vivo [84]–[86]. Some implant materials, such 
as electrically active ceramics, including polarized hydroxyapatite and piezoelectric ceramics, have been 
found to induce bone growth and improve bone formation around implants respectively [87]. The 
mechanism by which direct current influences biological responses is likely to result from preferential 
adsorption of proteins and ions onto the charged surface [88]. 
Numerous studies have emphasized the importance of these surface charges on cell behavior at 
the biomaterial interface [84], [85], [89]. In the calvarial bones of rats, after implanting electrically 
polarized hydroxyapatite plates, improved bone ingrowth and enhanced osteoblast activity have been 
observed, with complete bone penetration into the implants occurring as early as three weeks post-
stimulation application [84]. In another study, bone formation increases occurred on the negatively 
charged surfaces of the polarized implants due to a proven accumulation of Ca2+ ions on the negative 
surface and adherence of fibronectin, osteocalcin, and BMPs on the positively charged surfaces, thus 
improving osteoblast migration [84]. In addition, hyaluronan, an ECM component, has been found to plays 
a key role in the cellular interactions between charged surfaces and mediating initial contact between cell 
and attachment surfaces [90]. Although much is known about DC use, implementation of surface charge 
direct current stimulation treatment has been slow growing. 
Introduction to Direct Current Surface Charge Electrical Stimulator Systems 
Numerous works have shown direct electricity’s ability to promote osteogenesis in ADSC and 
BMDSC lines when they are seeded in bone scaffolds [91], [92]. However, typical DC electrical stimulators 
are either (a) externally housed and require overcomplex percutaneous wires be connected to the 
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implanted scaffold or (b) implanted non-degradable devices that contain toxic batteries and require 
invasive removal surgeries. Thus, a need exists for new strategies to deliver such stimulation. 
Introduction to Use of Piezoelectrics for Surface Charge Electrical Stimulators 
Piezoelectric materials, a type of smart material that can generate electrical surface charge from 
mechanical vibrations such as ultrasound, show much promise in this regard. These materials have been 
exploited extensively in industry for important external devices such as sensors, transducers, and 
actuators. Piezoelectric materials, however, also offer many significant medical applications when used 
inside the body[93]–[95]. For example, piezoelectric pressure transducers have been embedded inside 
percutaneous medical catheters to monitor dangerous elevations in physiological pressures including 
intracranial pressure[96], blood pressures[97], and bladder pressure[98]. Researchers have also reported 
an implantable piezoelectric ultrasonic transducer, which is more advantageous than external 
transducers, to disrupt the blood-brain barrier and facilitate the delivery of drugs into the brain [99]–
[101]. With these applications proving its efficacy to transform vibrational energy into electricity, 
piezoelectric technology is primed for use as a novel surface charge electrical stimulator for bone 
regeneration. 
Unfortunately, most commonly-used piezoelectric materials such as lead zirconate titanate (PZT), 
polyvinylidene fluoride (PVDF), zinc oxide (ZnO), and barium titanate (BaTiO3), etc. are either toxic and/or 
not biodegradable [102]. Implantable devices that utilize these materials require an invasive removal 
surgery which can easily damage interfaced tissues and lead to complications, raising a significant safety 
concern. The ability to create biodegradable and biocompatible piezoelectric materials can, therefore, 
bring about significant medical applications including as an electrical stimulator for bone regeneration. 
Introduction to Use of Poly-L-Lactic Acid for Surface Charge Electrical Stimulators 
Recently, poly-L-lactic acid (PLLA), a biocompatible and biodegradable medical polymer (used for 
many FDA-approved implantable devices such as surgical sutures[103], tissue scaffolds[104], and drug-
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delivery carriers[105]), has been shown to exhibit piezoelectricity when appropriately processed, thereby 
offering a much safer alternative piezoelectric material [106]. 
Classical processing of PLLA, which entails stretching an amorphous sheet of the material, and 
then annealing it has only yielded mild piezoelectric responses [106]. However, a few researchers have 
utilized electrospinning, a nanofiber production method that uses electric force to draw charged threads 
of polymer solutions onto a rotating collection plate, to create flexible PLLA nanofiber films which exhibit 
a higher level of piezoelectricity [107]–[109]. Typically, piezoelectric PLLA nanofibers struggle with 
stability, piezoelectric performance, and reliability [107]–[109]. However recent research in polymer 
processing has for the first time allowed the creation of biodegradable and biocompatible piezoelectric 
PLLA nanofibers with a highly-controllable, efficient, and stable piezoelectric performance. The PLLA 
nanofibers also offer a natural extracellular-matrix like environment to facilitate cellular growth for tissue 
regeneration. 
Thus here, a new tissue-stimulation approach, using a biodegradable piezoelectric PLLA nanofiber 
scaffold in combination with non-invasive ultrasound to generate electrical charges is demonstrated to 
enhance osteogenic differentiation of stem cells for eliciting bone-tissue regeneration. This strategy is 
analogous to the development of a wireless and battery-free, biodegradable, electrical-stimulator for 
bone growth.   
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Materials & Methods 
Step 1. Processing and Manufacturing of the Piezoelectric PLLA Nanofiber Mesh 
Unprocessed, PLLA (thought a polar molecule that has inherent charge separation) does not 
present with any piezoelectric properties, producing no electricity when mechanically stimulated. In order 
to improve the piezoelectric response of PLLA, two major material properties need to be improved to 
compound the charge separation to a point that the charge can be released - the crystallinity and the 
orientation of the polymer chain. By improving these properties, the carbon-oxygen double bonds present 
in the PLLA backbone become aligned resulting in an inherent net polarization and a well-documented 
piezoelectric response under an applied force. [110], [111] 
The PLLA nanofibers were fabricated using an in-house electrospinning setup shown in Figure 3 
[112]. Poly-L-Lactic acid granules (PURASORB PL38, Corbin Purac, Amsterdam, Netherlands) were used in 
this work. To create each PLLA mesh, 0.8g of PLLA was dissolved in a 1:4 V/V mixture of N, N – 
Dimethylformamide (DMF), anhydrous, ≥99.9%, MilliporeSigma, Burlington, MA) and dichloromethane 
(DCM, MilliporeSigma, Burlington, MA) respectively. The polymer solution was placed in a 10‐mL syringe 
which was loaded in a syringe pump (New Era Pump Systems Inc., Farmingdale, NY). The solution flow 
Figure 3. Piezoelectric PLLA Nanofiber Mesh Manufacturing Diagram: (a) Electrospinning setup 
with a 1:4 DMF:DCM v/v PLLA solution loaded into the syringe, a 14kV power source drawing out 
the solution, a rotating collection drum with an adjustable rotation speed between 300 and 4000 
rpm (b) Single, final PLLA nanofiber mesh 
Patel 21 
 
rate was 2 mL/hr through a flat-tipped 22-gauge needle (Jensen Global, Santa Barbara, CA) with 14kV 
applied to it. A grounded, aluminum rotating drum was positioned 8.6 cm from the needle tip, and a 
voltage potential was applied to the needle using a high voltage DC power supply (Gamma High Voltage, 
Ormond Beach, FL). The polarized solution was then sprayed at a grounded aluminum drum, wrapped in 
aluminum foil, rotating at speeds from 300 – 4000 rpm (rotations per minute). The relative humidity was 
monitored using a NIST‐certified hygrometer (Cole-Parmer, Vernon Hills, IL). The experiments were 
conducted in a 40 ±15 % relative humidity atmosphere at ambient temperature. 
This resulted in a PLLA nanofiber mat with varying degrees of alignment and fiber diameter, that 
varied with rotating drum speed. The nanofiber samples initially made by the electrospinning setup were 
expectedly highly amorphous. Therefore, the samples were annealed to further improve the material’s 
crystallinity. The samples were initially annealed at 105°C for 10 hours to initiate pre-crystallization and 
then slowly cooled to room temperature. Then the samples were annealed between Teflon FEP sheets 
(American DURAFILM, Holliston, MA) and glass slides at 160.1°C for 10 hours and again slowly cooled to 
room temperature. 
After the production of the PLLA nanofiber meshes, visualization of the films occurred via scanning 
electron microscopy (SEM). For each sample, a square PLLA film with dimensions 7mm x 7mm was 
mounted on a standard SEM pin (Ted Pella, Redding, CA) using carbon conductive tabs (Ted Pella, Redding, 
CA). The sample was then coated in gold-palladium for 1 minute using a sputter coater (Polaron E5100, 
Quorum Technologies Ltd., Lewes, UK). The sample was finally imaged using an FEI TeneoLoVac SEM at 
5kV and 2,500x magnification. These images can be seen in Figure 7 and Figure 8. These studies were 
performed at the University of Connecticut/Thermo Fisher Scientific Center for Advanced Microscopy and 
Materials Analysis).  
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With the films prepared, characterization of the films and verification of their piezoelectric 
efficiency (their ability to convert vibrational energy into electrical energy) was tested. The crystallinity of 
the PLLA nanofiber samples was analyzed using differential scanning calorimetry (DSC). The orientation 
of crystalline domains was visualized via 1-Dimensional & 2-Dimensional X-ray diffraction (XRD). 
Step 2. Verification of PLLA Nanofiber Mesh Efficacy and Degradation 
To verify the ability of the PLLA nanofiber mesh to generate surface charge in aqueous in vitro 
conditions, a test was conducted in which the PLLA mesh was submerged in solution, ultrasonically 
stimulated, and the electrical output was measured. To set up this experiment, first, gold electrodes were 
electrodeposited on two sides of a 1cm x 1cm square-cut PLLA mesh piece. Following this, they were 
covered by polydimethylsiloxane (PDMS) to waterproof the metal electrodes and then connected to 
PDMS-encapsulated copper wires. Gold electrodes were used to reduce the noise produced by the PLLA 
nanofiber. The PLLA with electrodes was then placed inside a medium of phosphate buffer solution (PBS) 
inside a sonication bath (Branson CPX 2800, Emerson Electric Co., St. Louis, MO). The PLLA mesh was 
under PBS while the two copper wires were connected to an electrometer to output the measured charge 
from the PLLA. As the surface charge outputted was dependent on the ultrasound stimulation, a range of 
ultrasound frequencies with different intensities was applied on top of the submerged PLLA mesh to 
engineer the piezoelectric outputs and optimize regenerative outcomes. Ultimately, the PLLA was 
stimulated with 40kHz 0.4W/cm2 ultrasound. The results of this can be seen in Figure 9. 
After verifying the piezoelectric capabilities of the processed PLLA nanofiber, a degradation study 
was performed to make sure that the electrospun PLLA follows a similar degradation as traditionally 
stretched PLLA, which has already been verified by the FDA to follow sufficient degradation standards. 
The experiment was performed, following a previous report [98]. The nanofiber meshes (n = 3 for each 
PLLA film type) were initially placed in PBS at 37°C. As PLLA has a long degradation time (about 180 days), 
a slightly sped up degradation study occurred [113]. From days 1-28, the PBS was maintained at a 
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physiological temperature of 37°C. From days 28 to 40 however, the PBS was doubled to 74°C. The results 
of the degradation study can be found in Figure 10. 
Step 3. Assembly of the PLLA Scaffold 
After verifying the single layer efficiency and degradation of the PLLA nanofiber mesh, a multi-
layered bone scaffold was produced. A diagram of this bone graft can be seen in Figure 4. This graft was 
produced by simply layering three Piezoelectric PLLA meshes alternated by layers of stem cells suspended 
in cell culture media. 
Ultimately, two main scaffolds were produced for the in vitro system test for osteogenic 
differentiation. The scaffolds used as the experimental group were spun at 3000 rpm and 1000 rpm. These 
scaffolds were compared to scaffolds spun at 300 rpm which served as a negative control group. 
Step 4. Test of Osteogenic Differentiation in vitro 
In the in vitro experiment, ADSCs and later BMDSCs were seeded on experimental piezoelectric 
PLLA films (3000 rpm and 1000 rpm films) and control, non-piezoelectric films (300 rpm films). These 
seeded scaffolds were then stimulated with 40 kHz, 0.4W/cm2 US for 20 minutes/day for 10 days to study 
osteogenesis. Five different experimental groups described in Figure 5 were used to test the efficacy of 
the entire system on enhanced osteogenesis. 
Figure 4. Diagram of the Completed PLLA Bone Graft: (macro image) The multi-layered scaffold seeded with stem cells. (micro image) 
A rat model showing a theoretical implantation and ultrasound stimulation site in a rat bone defect. 
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Prior to the start of the experiment, sterilization of the PLLA scaffolds and preparation of the cell 
culture plates occurred. The 1cm x 1cm scaffolds were sterilized using ethanol and UV treatment. The 
entire process was carried out under a Class II laminar flow cell culture hood. First, the scaffolds were 
soaked in 70% ethanol for 30 minutes. Then, the ethanol was removed, and the scaffolds were placed 
under UV light for 20 minutes on each side. This made the PLLA scaffolds suitable for cell seeding. 
Post sterilization, the scaffolds were fixed onto 6-well culture plates (Thermo Scientific) using 
biocompatible silicone glue (KWIK-SIL, World Precision Instruments). A small amount of glue was added 
to each well, spread across the entire surface using a spatula, and used to adhere the PLLA nanofiber 
scaffold. The glue was used to keep the scaffolds securely on the plate while the US treatments were 
carried out and used to prevent the ultrasound waves from getting reflected around by the walls of the 
polystyrene wells and getting dissipated in the process. After that, the plates were set aside to allow the 
glue to dry and the scaffolds to be secured in the plates. 
Cells were seeded onto the PLLA scaffolds after the latter were sterilized and glued to the plates. 
The cells used for this purpose were adipose-derived stem cells (XCells Biotechnologies) and were 
purchased at passage one. The cells, received in frozen, pelleted form, were thawed, plated, and 
expanded until passage five, as per the company protocol. For expanding the cultures, proliferation media 
Figure 5. Table of Experimental Groups: Group 1) 3000 rpm film treated with ultrasound. Group 2) 1000 rpm film treated with 
ultrasound. Group 3) 300 rpm film treated with ultrasound. Group 4) 3000 rpm film not treated with ultrasound. Group 5) 300 
rpm film not treated with ultrasound. 
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with 10 % fetal bovine serum and 1 % penicillin-streptomycin antibiotic solution was prepared in 
Dulbecco`s Modified Eagle Media (DMEM) (all three components purchased from Gibco). Expansion was 
carried out by passaging the cells every 5-6 days after the culture reached 80-90 % confluence. Ultimately, 
at 80-90 % confluence of passage five cells, they were detached from the flasks using Trypsin / 
Ethylenediaminetetraacetic acid (EDTA) (purchased from Gibco) and seeded onto the PLLA scaffolds at a 
seeding density of 5 x 105 cells per scaffold. The cells were allowed to attach for one day under 
proliferation media. After that, the 2mL of proliferation medium was replaced with an equal volume of 
osteogenic differentiation medium that was prepared by adding 50 µg/ml ascorbic acid and 10 mM beta-
glycerophosphate to the proliferation medium prepared previously [CITATION]. The cultures were left in 
osteogenic differentiation medium for one day before we started the daily ultrasonic treatments. 
After one day in differentiation media, the cells and scaffold began their 10-day US stimulation 
treatment. A diagram of this setup is seen in Figure 6. 
The treatment was performed using a sonication cleaning bath (Branson CPX 2800, Emerson 
Electric Co., St. Louis, MO). The ultrasound provided was at 40 kHz and 0.4W/cm2. The treatment was 
done for 20 minutes each day and performed for 10 days. First, the cell culture plate was sealed in a 
Figure 6. Diagram of Ultrasound Stimulation Setup: Schematic of the cell culture plate and ultrasound stimulation setup used 
for in vitro experiments. US was applied to every cell culture plate at 40kHz and 0.4W/cm2 for 20minutes/day for 10 days. 
Various piezoelectric PLLA films (3000 rpm and 1000 rpm meshes) and non-piezoelectric films (300 rpm meshes) were seeded 
with ADSCs or BMDSCs and stimulated with US to test the effect of surface charge on osteogenesis. 
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standardized manner. First, we taped the lid onto 4 sides of the plate using labeling tape. Then we 
removed the plate from the cell hood and encapsulated it in two layers each of plastic wrap (Kirkland 
Signature Stretch-Tite Plastic Wrap - 11 7/8 x750 Feet) and duct tape (manufactured by 3M). Three layers 
of plastic wrap were first applied in alternating orientations followed by a single layer of duct tape. Lastly, 
a centrally-placed tab was created on the top of the encapsulated plate to suspend the plate in the 
sonication water bath. This was done by using a laboratory clamp, stand apparatus, and an alligator clip. 
The plate was suspended so that it was submerged halfway into the water and horizontally level. The plate 
was sonicated for 20 minutes. When the treatment was complete for the day, the plate was removed 
from the bath, encapsulation layer removed, cell culture media change, and returned to the incubator 
until the next US treatment. 
Step 5. Assessment of Cell Proliferation and Differentiation 
After US treatment, three main cell proliferation and differentiation tests were conducted: an ALP 
quantification assay, an alizarin red quantification assay for CA2+ mineralization, and a quantitative 
polymerase chain reaction (qPCR) for gene expression measurement. After 10 days of treatment, the 
cultures were terminated and analyzed for osteogenic differentiation activity. 
ALP is an enzyme released by osteoblasts and pre-osteoblasts; its presence thus indicates the 
osteogenic differentiation of ADSCs. ALP activity measurement was carried out using a p-nitrophenyl 
phosphate (pNPP) based quantification kit (purchased from Bio-Rad, cat no-172-1063). The pNPP solution 
was prepared and added to the cellular protein extract and the ALP activity levels were quantified in 
accordance with the kit protocol. The standard curve for ALP-pNPP product quantification was prepared 
by dissolving different amounts of ALP (purchased from Sigma-Aldrich) in an aqueous solution, reacting 
them to pNPP, and reading the absorbance of each solution. This helped quantify the absolute ALP in our 
cultures. The values obtained were normalized by total protein content. The ALP data was normalized 
using total protein content measured using the bicinchoninic acid (BCA) assay (purchased from Pierce™). 
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The BCA assay (kit purchased from Pierce™, Thermo Scientific) was used to quantify the total 
protein content of the cultures. As per the kit protocol, a protein solution was extracted from each culture 
and was used to normalize the ALP assay described prior and the mineralization assay described below. A 
one-way analysis of variance (ANOVA) test and a Tukey’s Honest Significant Difference (HSD) test was 
used to assess significance. 
As mineral deposition, especially of Ca2+, is a common property of bone cells, the alizarin red assay 
was used to quantify the amount of the Ca2+ mineral formed by the cells seeded in each group. For the 
alizarin red assay, the cultures were fixed in 70% ethanol at 4°C for one hour. Following this, the ethanol 
was removed, the wells were rinsed and the alizarin red dye (purchased from EMD Millipore corp.) was 
added and the cultures were incubated at room temperature for 30 minutes. After this incubation period, 
the dye was rinsed away, and the wells were viewed under the microscope to observe the then stained 
red mineral formation. Quantification of the red mineral formation was done by de-staining the red dye 
in cetyl-pyridinium chloride (purchased from Sigma Aldrich), measuring its absorbance, and equating that 
to the absolute concentration of Ca2+ produced. The values obtained were lastly normalized by total 
protein content using the BCA assay described prior. 
To measure the expression of osteocalcin and osterix genes, which are typical osteogenic 
differentiation markers, qPCR was conducted. qPCR quantification was performed using the universal sybr 
green master mix (purchased from Bio-Rad). The forward primer used for osterix was: 5’-GGA AAG GAG 
GCA CAA AGA A-3’ and the reverse sequence used was 5’-GTC CAT TGG TGC TTG AGA A-3’. The forward 
primer used for osteocalcin was 5’-CAA GCA GGA GGG CAA TAA G-3’ and the reverse primer was 5’-CGT 
CAC AAG CAG GGT TAA G-3’ (purchased from Integrated DNA Technologies). The corresponding protocol 
for the qPCR kit and primers was used to guide the qPCR process. Extraction of RNA was performed using 
the Trizol reagent, the extracted RNA was converted to cDNA using the iScript cDNA synthesis kit 
(purchased from Bio-rad), the cDNA was mixed with the appropriate primers and the master mix and run 
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through an RT-qPCR machine (purchased from ABsystems) to get the gene expression values. These values 
were normalized with a qPCR assay of beta-actin, a common housekeeping gene. The beta-actin forward 
primer used was 5’-TCC TCC TGA GCG CAA GTA CTC T-3’ and the reverse primer was 5’-CGG ACT CAT CGT 
ACT CGT GCT T-3’). A one-way ANOVA test and a Tukey’s HSD test was used to assess significance. 
In addition to ADSCs, the ability of the piezoelectric nanofiber scaffold under an applied US to 
induce osteogenesis from bone marrow stem cells was also investigated. Specifically, a fluorescent 
reporter BMDSC system was utilized to monitor the proliferation and differentiation of our cells in real-
time and to confirm the osteogenic properties of our PLLA system. The reporter cells used were primary 
BMDSCs with a topaz green fluorescent protein reporter for bone sialoprotein (BSP-GFP-topaz) and a 
mCherry red fluorescent protein reporter for dentin matrix protein (DMP1-RFP-mCherry) tag. This cell line 
was harvested from the tibial and femoral bone marrows of 3 to 4-week-old dual transgenic mice 
containing BSP-GFP-topaz and DMP1-RFP-mCherry fluorescent reporter genes. 
The progressive expression from BSP to DMP was used to determine the different stages of 
differentiation BMDSCs go through. Optical imaging was used to visually compare the osteogenic 
properties of different scaffold types and treatments. At days 0 (pre-seeding), 1, 2, and 3 of US treatment, 
reporter cell fluorescence (n=3) was captured using the Zeiss Axio Observer Z.1 inverted fluorescence 
microscope. The fluorescence of the cells was captured by taking sectional images of the entire scaffold 
surface in ZEN software at an objective of 5X. Exposure times of 100 ms and 1000 ms were applied for 
both the BSP-GFP-topaz and the DMP1-RFP-mCherry channels. The sectional images obtained were then 
stitched together to create a mosaic. The final images obtained showed different amounts of green and 
red fluorescence for different scaffolds receiving different treatments. The amount of fluorescence in each 
image was quantified using the ImageJ software and the relative fluorescence of each group was 




Step 1. Processing and Manufacturing of the Piezoelectric PLLA Nanofiber Mesh 
As the speed of the rotating drum was varied from 300 rpm – 4000 rpm, the PLLA nanofiber films 
were produced with different levels of fiber orientation. This can be seen in Figure 7 and Figure 8. 
s 
s 
Figure 7. SEM Images of Non-Piezoelectric PLLA Nanofiber Film: 300 rpm Non-
Piezoelectric PLLA film confirming the poor orientation of the nanofibers. 
Figure 8. SEM Images of Piezoelectric PLLA Nanofibers: PLLA films produced at 1000 rpm – 4000 rpm, confirming higher 
electrospinning rotation speed increases fiber alignment. Scale bars are all 40 µm. 
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Step 2 & 3. Verification of PLLA Nanofiber Mesh Efficacy and Degradation & Assembly of 
the PLLA Scaffold 
 Ultimately, the 3000 rpm film was proven to output +/- 40mV of electrical surface charge when 
stimulated with 40kHz 0.4W/cm2 ultrasound. The untreated, 300 rpm film shows only noise and has no 
change in electrical output when US is applied. This can be seen in Figure 9. 
 With the piezoelectric efficacy of the experimental 3000 rpm film confirmed, a degradation study 
was done on the PLLA nanofiber. The graft of this degradation can be seen in Figure 10. 
Figure 10. Graph of PLLA Degradation Study: Remaining weight (%) of piezoelectric PLLA 
films degraded in PBS for 40 days. Initially, the temperature of the PBS was a physiologic 
37°C. On day 28, this was doubled to 74°C to speed up degradation. 
Figure 9. Verification of PLLA Piezoelectric Output: (Right) Schematic of PLLA 
scaffold testing done in a salt bath with electrical output read by an oscilloscope. 
(Left) Piezoelectric voltage output when 40kHz ultrasound is off versus on. 
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Step 4 & 5. Test of Osteogenic Differentiation in vitro & Assessment of Cell Proliferation 
and Differentiation 
On day 10 of the cell culture tests, three assays were done on the ADSCs and the BMDSCs. The 
results of these assays are below. In total, there were 5 groups, which can be seen in Figure 5. The results 
of the ADSCs assays can be seen in Figure 11 and Figure 12.  
The results of the subsequent gene expression assays for the ADSCs are displayed in Figure 12. 
Following ADSC studies, reporter BMDSC studies were conducted. Figure 13 shows the results of 
the assessment of BMDSC reporter differentiation. Figure 13a shows the differentiation pathway from 
progenitor stem cells to differentiated osteocyte. Figure 13b consists of fluorescent images of the cells in 
different experimental conditions. Figure 13c shows the florescent expressions quantitively and provides 
a graphical comparison between each group. 
Figure 11. ADSC Protein and Mineral Expression Test Results: (a) Quantitative comparison of ALP production by the cells in 
different treatment groups. (b). Comparison of Ca2+ production by the cells in different treatment groups. A one-way ANOVA and 
a Tukey’s HSD test was used as a test of significance. In the figure, † represents a significance level of 0.01, †† represents a 
significance level of 0.001, and ††† represents a significance level of 0.0001. 
Figure 12. ADSC Gene Expression Test Results: (a) Osteocalcin gene levels by the cells in different treatment groups (b) Osterix 
gene levels by the cells in different treatment groups. Both genes levels were normalized to the gene expression of beta-actin. A 
one-way ANOVA and a Tukey’s HSD test was used as a test of significance. In the figure, † represents a significance level of 0.01, 




Figure 13. BMDSC Reporter Cell Activity: This figure shows the florescent expressions of primary bone marrow stem cells 
(BMDSCs) with reporters for bone sialoprotein (BSP-GFP-topaz) and dentin matrix protein (DMP1-RFP-mCherry) when seeded 
on electrospun PLLA scaffolds and exposed to US treatment. These reporter stem-cells fluoresce green and red when 
differentiated into osteoblasts and osteocytes respectively, two signs of eliciting bone regeneration. (a) Schematic of the 
progressive expression from Stem Cell to differentiated Osteocyte. (b) Fluorescent microscopy of the cells seeded on different 
scaffolds in different treatment groups through the GFP channel (100ms exposure time) and the cherry red channel (1000ms 
exposure time). (c) Quantitative fluorescent expressions and graphical comparison of between each group. A one-way ANOVA 
and a Tukey’s HSD test was used as a test of significance. In the figure, † represents a significance level of 0.01, †† represents a 




Ultimately, as expected, nanofibers from were made with varying piezoelectricity, based on the 
rotational speed of the electrospinning collecting drum. As can be seen in Figure 7 and Figure 8, the 
nanofiber films, collected at slow spin-speeds, have lower levels of fiber alignment, thus offering lower 
piezoelectric effects. Past literature has reported a positive relationship between electrospinning 
collecting drum speed and crystallinity of the nanofiber material [104]. Consistently, as seen in Figure 8, 
the 3000 rpm and 4000 rpm samples have the best fiber alignment. Higher speeds were not tested due 
to reported strain overload on the fibers that can break them when spun at such high speeds [104]. For 
this reason, the 3000 rpm film was chosen as the positive, experimental PLLA control group and the 300 
rpm film was used for the negative control group. 
When the 3000 rpm film was tested in a salt-bath solution, it was proven to output +/- 40mV of 
electrical surface charge when stimulated with 40kHz 0.4W/cm2 ultrasound. This can be seen in Figure 9. 
Also in Figure 9, however, is significant noise from the non-piezoelectric 300 rpm film. Earlier studies of 
PLLA electrospun films produced at this speed have shown that they are not oriented enough to allow for 
sufficient charge polarization to create usable electricity, still significant noise was seen [109]. Related 
research on PLLA stimulation has found that PLLA also exhibits another electricity-making effect called the 
triboelectric effect [114]–[116]. Triboelectric materials become electrically charged after they are 
separated from a previously-in-contact different material [114]–[116]. The filtered, useful +/- 40mV 
voltage falls within a clinically proven range of electrical stimulation that has been proven to be beneficial 
for bone regeneration [66].  
With the piezoelectric efficacy of the experimental 3000 rpm film confirmed, a degradation study 
was done on the PLLA nanofiber to confirm its degradation matched that of the FDA approved, stretched 
PLLA polymer. The graft of this degradation can be seen in Figure 10. Although standard PLLA has a proven 
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degradation time of approximately 180 days, a 40-day study was conducted here. Over the course of the 
first 28 days, there was minimal change in the weight of all films [117]. To illustrate the influence of 
processing condition on degradation, the temperature was increased to 74˚C on day 28 to accelerate the 
film erosion. Still, both the standard, FDA-approved stretched compression-molded PLLA film and the 
electrospun sample, collected at 3000 rpm, degrade at similar rates. By day 40, both samples were at 
approximately 60% of their original weight. While this is the result of an accelerated degradation, the 
trend is expected to hold for degradation studies performed over a longer period of time at 37˚C. Optimal 
degradation studies have a constant downward trend, reflective of the fact that once degraded, a material 
cannot be rebuild. Figure 10 data however has an upward spike on day 20 and day 32, representing a 
theoretical gain in mass of the PLLA nanofiber. While water absorption into a sample has been shown to 
result in this [118], it should not be occurring in a material such as PLLA. Again, this provides another point 
of investigation. 
Following verification of efficiency and degradation for the PLLA, the entire system was tested. 
Figure 5 shows all the experimental groups utilized. Figure 11 shows the protein and mineralization 
expression of these groups and Figure 12 shows the gene expression of these groups. In Figure 11a, the 
groups of 3000 rpm PLLA + US and 1000 rpm PLLA + US have significantly higher (p<0.0001) expressions 
of ALP than the other three groups. In addition, the 3000 rpm + US (with more piezoelectric charge) has 
significantly higher ALP production compared to the 1000 rpm + US (with less piezoelectric charge) 
(p<0.001). Figure 11b demonstrates that the groups of 3000 rpm PLLA + US and 1000 rpm PLLA + US have 
significantly higher (p<0.0001) mineral formation as compared to the other sham/control groups. Similar 
to the ALP assay, the 3000 rpm + US group has significantly higher mineral formation when compared to 
the 1000 rpm + US group (p<0.001). Figure 12a and Figure 12b show that the 3000 rpm and 1000 rpm 
PLLA + US show significantly higher levels of both osteocalcin (p<0.0001) and osterix (p<0.0001) 
expression respectively when compared to the other groups. Again, the 3000 rpm PLLA + US group has 
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significantly higher expression of both genes as compared to the 1000 rpm + US group, illustrating that 
more surface charge generates more osteogenesis. These findings support current findings that mild 
direct current electrical stimulation increases stem cell ALP production and Ca2+ production [66]. 
Reporter BMDSC studies were conducted to measure the active expression of proteins in culture. 
Figure 13b shows different experimental groups receiving different treatments as observed under the BSP 
mCherry channel and DMP1 cherry red channel. The increase in green and red fluorescence progressively 
from the non-piezoelectric 300 rpm PLLA films to the highly piezoelectric 3000 rpm PLLA films shows the 
clear increase in osteogenesis as surface charge increases and approaches +/- 40mV. In Figure 13c, it can 
be seen that the BMDSC reporter genes are turned on significantly when the cells are cultured on the 
piezoelectric 1000 rpm and 3000 rpm PLLA nanofiber scaffolds under applied US, compared to the other 
control/sham samples. This result, like the ADSCs presented in Figure 11, demonstrates the effect of 
piezoelectric charge on osteogenic differentiation of stem cells. 
The fact that PLLA was successfully used in combination with externally applied ultrasound to 
produce an electric surface charge that could stimulate stem cell osteogenesis is extremely significant to 
the field of bone regeneration. Prior to this novel surface charge electrical stimulation setup, electrical 
stimulators relied on externally housed power sources or implanted non-biodegradable batteries [69]. 
The prior, typically required overcomplex and uncomfortable percutaneous wires to be connected to the 
implanted scaffold and the latter, the battery, often contained toxic chemicals and required invasive 
removal surgeries. With a safe method of surface charge, electrical stimulation now proved, one hurdle 
slowing the implementation of surface charge stimulation for treatment of bone fractures and bone 
defects has been overcome [69]. 
Still, there is much that can be improved about this PLLA nanofiber – ultrasound system. Current 
manufacturing methods for electrospun PLLA limit the level of alignment and thus the level of 
Patel 36 
 
piezoelectricity that can be achieved [104]. While this processing method is certainly superior to the 
classic drawing and annealing method, it still does not yield a piezoelectric response as significant as some 
of the classic piezoelectric materials (PZT, PVDF, ZnO, or BaTiO3) [102]. Improved future processing of PLLA 
could allow for biodegradable implants that output ever greater levels of surface charge – levels that may 
be clinically significant to other cell lines and for use in other treatments [119]. 
Besides the piezoelectric processing method of PLLA, the 3D scaffold structure is another area for 
future investigation. Current technologies limit us to simple stacking of piezoelectric PLLA, however, 
research has found that more complex 3D structures can elicit even greater stem cell proliferation and 
differentiation [120]. This provides another avenue for the improvement of this PLLA-ultrasound system. 
On the ultrasound end, in this study, stimulation only occurred from a single, inferior direction. 
However, stimulating a 3D scaffold requires multidimensional ultrasound stimulation [121]. This again 
offers another opportunity to increase the achieved piezoelectric output from a PLLA scaffold. 
Despite all these potential future directions, there is unknown about the long-term benefits or 
risks of ultrasound stimulation and electrical stimulation [122]. As in vivo research has not yet been 
conducted, tissue damage from extended ultrasound application or from escaping electrical charge has 
not been studied. Additionally, the effect of said ultrasound and resulting electricity may be a hindrance 
to vascular flow and miscellaneous cellular growth [6]. These limitations will have to be investigated in 
follow up studies. 
Overall, this advancement helps make tissue engineering a treatment option that can be ever more 
broadly applied. The development of a biodegradable electric stimulator has many applications outside 
of bone growth generators. This system could be used to power and wirelessly charge implantable 
batteries, such that they never need to be invasively extracted or replaced. Neurostimulators that use 
small electrical shocks to disrupting certain signals (often pain signals) traveling through the brain could 
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be one potential benefactor of this technology [123]. Pacemakers and implantable cardiac defibrillators 
are another [123]. Implementation of a piezoelectric PLLA scaffold could be used to harness external 
ultrasound vibrations and output them as electrical current to power these medical implants. Without the 
need for these invasive battery replacement surgeries or the need for percutaneous leads to be inserted, 
fewer complications from these surgeries will occur, fewer resources are needed as no follow-up surgery 
is required, and most important patient lives will be benefited. 
The novel biodegradable PLLA piezoelectric device described herein is expected to have a profound 





Ultimately, the production of surface-level electrical charge from ultrasonic stimulation of PLLA 
and the use of that charge to promote osteogenic differentiation in ADSC and reporter BMDSC lines was 
successfully demonstrated. The assays of both ADSCs and reporter BMDSCs demonstrate this 
achievement from a cellular activity standpoint, with both of these differentiated cell lines successfully 
carrying out their typical roles in bone growth and repair. 
This research presents a novel biodegradable piezoelectric PLLA nanofiber scaffold with stable, 
effective, and highly controllable piezoelectric performance that uses only common biodegradable and 
biocompatible materials. The PLLA nanofibers and the novel biodegradable piezoelectric device described 
herein are expected to have a profound impact on the use of piezoelectrics for surface charge stimulation 
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